Human embryonic stem cells are of immense interest to researchers because of their ability to potentially develop into any kind of tissue.
Beatriz San Martin
Advertisement
Beatriz San MartÃn is a solicitor in the IP department at Field Fisher Waterhouse and is a member of the Life Sciences & Healthcare group. She is also a member of Pharmaceutical Technology Europe’s Editorial Advisory Board.
Articles by Beatriz San Martin
Advertisement
Latest Updated Articles
Embryonic stem cells: the moral dilemma of patentability and fundingPublished: September 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
2
AAPS PharmSci 360 2025: Trends in Bioanalysis
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
